FDA Inspection 1095554 — University of Pittsburgh Cancer Institute Cancer Service

University of Pittsburgh Cancer Institute Cancer Service — FEI 3000203655

The FDA completed an inspection of University of Pittsburgh Cancer Institute Cancer Service on June 24, 2019 in Erie, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.

Inspection Details

Classification
No Action Indicated (NAI) (NAI)
End Date
June 24, 2019
Fiscal Year
2019
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Erie, PA (United States)